Form 4 for DNLI Denali Therapeutics Inc.
Accepted 2021-09-17 00:00:00 ET · period of report 2021-09-15 · accession 0001714899-21-000091 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-09-17 | 2021-09-15 | DNLI | SATO VICKI L | Dir | S - Sale | $53.40 | -1,666 | 130.3K | -1% | -$89.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-15 | S | D | 230 | $52.28 | 130,935 | D | — | — | (F2) The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $51.56 to $52.55 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. (F3) Includes 2,074 restricted stock units. |
| 2 | Common | Common Stock | 2021-09-15 | S | D | 140 | $54.76 | 129,499 | D | — | — | (F6) The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $54.63 to $54.89 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. (F3) Includes 2,074 restricted stock units. |
| 3 | Common | Common Stock | 2021-09-15 | S | D | 620 | $53.92 | 129,639 | D | — | — | (F5) The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $53.57 to $54.55 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. (F3) Includes 2,074 restricted stock units. |
| 4 | Common | Common Stock | 2021-09-15 | S | D | 676 | $53.03 | 130,259 | D | — | — | (F4) The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $52.56 to $53.48 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. (F3) Includes 2,074 restricted stock units. |